4.70
price down icon0.42%   -0.02
 
loading
前日終値:
$4.72
開ける:
$4.51
24時間の取引高:
4.25M
Relative Volume:
1.29
時価総額:
$418.32M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-19.38%
1か月 パフォーマンス:
-8.38%
6か月 パフォーマンス:
+21.76%
1年 パフォーマンス:
+141.03%
1日の値動き範囲:
Value
$4.465
$4.755
1週間の範囲:
Value
$4.465
$7.2904
52週間の値動き範囲:
Value
$1.67
$7.2904

Atyr Pharma Inc Stock (ATYR) Company Profile

Name
名前
Atyr Pharma Inc
Name
セクター
Healthcare (1164)
Name
電話
(858) 731-8389
Name
住所
10240 SORRENTO VALLEY ROAD, SAN DIEGO
Name
職員
59
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ATYR's Discussions on Twitter

ATYR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATYR
Atyr Pharma Inc
4.70 420.10M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-18 開始されました Leerink Partners Outperform
2025-01-06 開始されました Cantor Fitzgerald Overweight
2024-10-04 開始されました Wells Fargo Overweight
2024-09-05 開始されました Jefferies Buy
2023-07-05 ダウングレード Oppenheimer Outperform → Perform
2021-10-12 開始されました RBC Capital Mkts Outperform
2021-09-21 開始されました Piper Sandler Overweight
2021-05-10 開始されました Laidlaw Buy
2020-08-17 アップグレード H.C. Wainwright Neutral → Buy
2020-03-04 開始されました ROTH Capital Buy
2020-03-02 開始されました Oppenheimer Outperform
2018-02-14 ダウングレード JP Morgan Neutral → Underweight
2017-09-07 開始されました Piper Jaffray Overweight
2016-12-13 ダウングレード JP Morgan Overweight → Neutral
2015-12-16 開始されました Citigroup Neutral
2015-06-01 開始されました Citigroup Buy
2015-06-01 開始されました JP Morgan Overweight
すべてを表示

Atyr Pharma Inc (ATYR) 最新ニュース

pulisher
Jul 31, 2025

Martin Shkreli Is Shorting This ‘Strong Buy’ Penny Stock. How Should You Play Shares Here? - Yahoo Finance

Jul 31, 2025
pulisher
Jul 30, 2025

Price Channel Expanding on aTyr Pharma Inc.’s ChartReal Time Stock Movement Analysis Indicates Breakout - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), aTyr Pharma (ATYR) and HCA Healthcare (HCA) - The Globe and Mail

Jul 30, 2025
pulisher
Jul 29, 2025

Price Consolidation Hints at Upcoming Move in aTyr Pharma Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Wyckoff Accumulation Phase Possible in aTyr Pharma Inc.Entry Plan for Oversold Reversal Stocks Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Will aTyr Pharma Inc. Recover After Recent DeclineMarket Momentum Signal Generator Shows Trends - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

aTyr Pharma Inc put volume heavy and directionally bearish - TipRanks

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 07:01:04 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

aTyr Pharma Inc. Breakout Confirmed by Volume MetricsWatchlist for Smart Swing Trading Updated - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What makes aTyr Pharma Inc. stock price move sharplyTrend Analysis for Safer Trades Gains Popularity - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

aTyr Pharma Stock Faces Market Scrutiny Amid Financial Challenges - StocksToTrade

Jul 28, 2025
pulisher
Jul 28, 2025

aTyr Pharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Entry and Exit Point Tips From Traders - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What is aTyr Pharma Inc. company’s growth strategyMaximize returns with data-driven strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy aTyr Pharma Inc. stockAchieve breakthrough gains with smart trades - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about aTyr Pharma Inc.Free Consultation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does aTyr Pharma Inc. generate profit in a changing economyFree Stock Recommendation For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are aTyr Pharma Inc. company’s key revenue driversGet daily updates on the hottest stocks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How volatile is aTyr Pharma Inc. stock compared to the marketUnstoppable trading performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Is aTyr Pharma Inc. a good long term investmentUnprecedented market success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Does aTyr Pharma Inc. stock pay reliable dividendsHigh-performance investment picks - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

RNA Therapeutics and Vaccines Market Industry Trends & Forecasts to 2035, with Profiles of Alphavax, Arcturus Therapeutics, aTyr Pharma, Gritstone Bio, HDT Bio, MiNA Therapeutics, & VLP TherapeuticsResearchAndMarkets.com - FinancialContent

Jul 25, 2025
pulisher
Jul 23, 2025

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Benzinga

Jul 23, 2025
pulisher
Jul 23, 2025

aTyr Pharma Soars 11.26% on Phase 3 Study Completion - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

aTyr Pharma stock holds Buy rating as Phase 3 trial completes - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

High-Risk, High-Reward Opportunity in aTyr Pharma’s Efzofitimod Amid Upcoming Phase 3 Readout - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about aTyr Pharma Inc. stockMarket-leading capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

aTyr Pharma Announces Last Patient Visit in Phase 3 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives aTyr Pharma Inc. stock priceMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

aTyr Pharma Inc. Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

aTyr Pharma announces last patient visit in Phase 3 EFZO-FIT study - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

First-Ever Global Phase 3 Trial for Sarcoidosis Treatment Reaches Major Milestone with 268 Patients - Stock Titan

Jul 22, 2025

Atyr Pharma Inc (ATYR) 財務データ

Atyr Pharma Inc (ATYR) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Atyr Pharma Inc (ATYR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Broadfoot Jill Marie
Chief Financial Officer
Feb 04 '25
Sale
3.78
1,254
4,740
31,763
DENYES NANCY
General Counsel
Feb 04 '25
Sale
3.78
899
3,398
26,555
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):